RELATIONSHIP BETWEEN CLINICAL MANIFESTATIONS AND ANTIBODY SERUM IN OUTBREAKS ANTHRAX
Downloads
Introduction: Anthrax is a zoonotic disease that often affects the grass-eating animals, which occurs due to the entry of spores into the bodies of animals and can be transmitted to humans. This disease often appear in certain seasons and occurs in endemic areas, including Indonesia. Cutaneous anthrax is the clinical manifestations that often arise on outstanding events in the area. This study aims to determine how the relationship between the clinical manifestations of the serum antibodies in people who are exposed to anthrax. Material and methods: This study is an observational cross sectional analytic approach, in people exposed to anthrax to assess the clinical manifestations and antibody serum Anthrax. Results: Obtained in this study respondents were 101 people with a history of contact with animals suffering from anthrax. The number of respondents with the highest age distribution was 31 to 40 years by 42%, and most were female gender, which is 57.7%, the highest level of education is 74% finished elementary school. Forty-four percent of working as a housewife. Risk factors are the most direct contact with and consume the flesh of animals as much as 34.6%. Results of Ig G antibody serum showed 50% negative, 15.4 borderline and 34.6% positive. Clinical manifestations that occur in the skin as much as 13.5%, that is the eschar on all respondents and 92.8% showed positive Ig G. While 86.5% did not show any clinical signs of anthrax, of that number 25.5% with Ig G positive, 16.6% and 57.7% showed borderline negative with p 0.02. Conclusion: There was a significant association between the clinical manifestation with antibody serum anthrax. But also found a positive Ig G without the appearance of clinical signs in the skin.
Jeremy Farrar, Peter J. Hotez, Thomas Junghanss, Gagandeep Kang, David Lalloo and Nicholas J. White; Anthrax ; Manson's Tropical Diseases; 2014; 31, 395-398.e1.
Fred F. Ferri; Anthrax; Ferri's Clinical Advisor 2015; Mosby, an imprint of Elsevier Inc; 2014; 115.e2-115.e4.
Redhono, Paramasari. Anthrax Outbreaks in Indonesia. Proceeding in APSIC 2011 - The 5th International Congress of the Asia Pacific Society of Infection Control. Melbourne ; 2011: 152.
Redhono D, Sumandjar T, Hermawan G Pemetaan antraks di jawa tengah. Antraks: Sebelas Maret press; 2011: 11–17.
Dirgahayu P Pemeriksaan laboratorium deteksi antraks berbasis immunoassay. Antraks : Sebelas Maret press; 2011: 18–26.
Dixon TC, Meselson BSM, Guillemin J, Hanna PC Anthrax. N Engl J Med; (2005) vol. 341 p. 815–826.
Pile JC, Malone JD, Eitzen EM, Friedlander AM. Anthrax as a potential biological warfare agent. Arch Intern Med; 2005 vol 158 p. 429–34.
Shafazand S, Doyle R, Ruoss S, Weinacker A, Raffin TA Inhalation anthrax, Epidemiology, diagnosis and management. Chest ; 2005 vol 116 p. 1369–1376.
John E. Bennett, Raphael Dolin and Martin J. Blaser; Anthrax; Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases; Saunders, an imprint of Elsevier Inc; 2015; 209, 2391 2409.e2.
Inglesby TV, Henderson DA, Barlett JG Anthrax as a biological weapon medical and public health management. JAMA; 2005 vol 281 p. 1735–1745.
Holmes RK. Diphtheria, other corynebacterial infection and anthrax. In : Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, et al. Eds. Harrison's Principles of Internal Medicine. 16th ed. McGraw-Hill ; New York; 2009: 892–899.
The Indonesian Journal of Tropical and Infectious Disease (IJTID) is a scientific peer-reviewed journal freely available to be accessed, downloaded, and used for research. All articles published in the IJTID are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which is under the following terms:
Attribution ” You must give appropriate credit, link to the license, and indicate if changes were made. You may do so reasonably, but not in any way that suggests the licensor endorses you or your use.
NonCommercial ” You may not use the material for commercial purposes.
ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
